On Monday, Olema Pharmaceuticals Inc (NASDAQ: OLMA) opened lower -8.78% from the last session, before settling in for the closing price of $6.15. Price fluctuations for OLMA have ranged from $5.56 to $16.77 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -7.49% at the time writing. With a float of $42.88 million, this company’s outstanding shares have now reached $57.29 million.
In an organization with 74 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 85.67%, operating margin of -7213.69%, and the pretax margin is -6511.62%.
Olema Pharmaceuticals Inc (OLMA) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Olema Pharmaceuticals Inc is 25.17%, while institutional ownership is 84.98%. The most recent insider transaction that took place on Dec 17 ’24, was worth 4,730,137. In this transaction Director of this company sold 700,761 shares at a rate of $6.75, taking the stock ownership to the 0 shares. Before that another transaction happened on Dec 13 ’24, when Company’s Affiliate proposed sale 700,761 for $6.75, making the entire transaction worth $4,730,137.
Olema Pharmaceuticals Inc (OLMA) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.62 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -7.49% per share during the next fiscal year.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
Check out the current performance indicators for Olema Pharmaceuticals Inc (OLMA). In the past quarter, the stock posted a quick ratio of 7.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.19, a number that is poised to hit -0.64 in the next quarter and is forecasted to reach -2.65 in one year’s time.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
Let’s dig in a bit further. During the last 5-days, its volume was 0.86 million. That was better than the volume of 0.77 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 36.03%. Additionally, its Average True Range was 0.69.
During the past 100 days, Olema Pharmaceuticals Inc’s (OLMA) raw stochastic average was set at 0.64%, which indicates a significant decrease from 1.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 109.72% in the past 14 days, which was higher than the 74.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.62, while its 200-day Moving Average is $11.24. However, in the short run, Olema Pharmaceuticals Inc’s stock first resistance to watch stands at $5.98. Second resistance stands at $6.34. The third major resistance level sits at $6.54. If the price goes on to break the first support level at $5.42, it is likely to go to the next support level at $5.22. Assuming the price breaks the second support level, the third support level stands at $4.86.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Key Stats
There are currently 57,298K shares outstanding in the company with a market cap of 312.79 million. Presently, the company’s annual sales total 0 K according to its annual income of -96,660 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -34,560 K.
